Mismatch repair deficiency (dMMR) testing can be performed by immunohistochemistry in paraffin sections using commercially available antibodies evaluating the expression of four MMR proteins (MLH1, PMS2, MSH2 and MSH6) in tumor cell nuclei or by PCR, as mention above. The gene discussed is MSH2; the disease is mismatch repair cancer syndrome 1.